Plant DNMT3 Fusion Proteins for Targeted CHH and CpG Methylation

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

The role of plant DNA methyltransferase 3 (DNMT3) orthologs in DNA methylation has remained elusive, particularly in angiosperms, and their potential applications in non-plant systems like mammals have not been explored.

Innovation Solution

Development of a fusion protein comprising a DNA targeting moiety linked to a catalytic domain of a plant DNMT3 protein, specifically utilizing a DNA endonuclease protein like Cas9, optimized for expression in non-gymnosperm and non-bryophyte organisms, which enhances methylation at CHH and CpG sites.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If plant DNMT3 is used in angiosperms, then de novo methylation can be achieved, but the function remains elusive and uninvestigated

Engineering Contradiction:
Improvemethylation functionVSAvoidfunctional knowledge
Core Design Contradiction:
ReliabilityVSLoss of information

Solution Approach 1:

The patent uses a fusion protein approach where plant DNMT3 is combined with a DNA targeting moiety (such as dCas9) to create an intermediary system that can deliver methylation activity to specific genomic locations. This mediator system enables functional investigation of plant DNMT3 in angiosperms where it was previously uninvestigated, resolving the contradiction between having the enzyme and lacking functional knowledge.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Adaptability or versatility

If DNMT3 is expressed in mammalian cells, then methylation activity can be demonstrated, but the enzyme is plant-specific and may not function naturally in mammals

Engineering Contradiction:
Improvecross-species functionalityVSAvoidenzymatic function
Core Design Contradiction:
Adaptability or versatilityVSReliability

Solution Approach 1:

The patent creates a universal methylation system by fusing plant DNMT3 with a DNA targeting moiety that can function in both plant and mammalian cells. The catalytic domain of plant DNMT3 retains its methyltransferase activity when expressed in mammalian cells, demonstrating cross-species functionality while maintaining reliable enzymatic function through the conserved catalytic domain.

Inventive Principle:
Principle #6Universality (Multi-functionality)

3Measurement precision

If fusion protein with DNA targeting moiety is created, then precise methylation at specific sites is achieved, but the device complexity increases

Engineering Contradiction:
Improvemethylation site precisionVSAvoidfusion protein structure
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The patent segments the methylation system into two functional parts: a DNA targeting moiety (such as dCas9) that provides site-specificity and a catalytic domain of plant DNMT3 that provides methylation activity. This segmentation allows each component to perform its specific function independently while working together to achieve precise methylation at desired genomic sites.

Inventive Principle:
Principle #1Segmentation

4Productivity

If plant DNMT3 is used instead of human DNMT3, then higher methylation efficiency at CHH and CpG sites is achieved, but the enzyme is optimized for plant genomes

Engineering Contradiction:
Improvemethylation efficiencyVSAvoidgenome compatibility
Core Design Contradiction:
ProductivityVSAdaptability or versatility

Solution Approach 1:

The patent changes the parameters of the methylation system by using plant DNMT3 instead of human DNMT3, taking advantage of the higher methylation efficiency of plant DNMT3 at CHH and CpG sites. The fusion protein approach allows this parameter change while maintaining genome compatibility through the DNA targeting moiety that can guide the enzyme to specific locations in both plant and mammalian genomes.

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The fusion protein effectively increases DNA methylation at CHH and CpG sites in mammalian and plant cells, demonstrating higher methylation efficiency compared to human DNMT3, and regulates gene expression.

Implementation Method 1

DNA methylation, the addition of a methyl group to a cytosine base, is a prominent epigenetic modification in many eukaryotes. It is catalyzed by distinct DNA methyltransferase (DNMT) families of proteins that share a conserved methyl-transferase domain (MTD).

Methodology Applied
Scientific EffectDNA methylation: Chemical Bonding

Implementation Method 2

The fusion protein effectively increases DNA methylation at CHH and CpG sites in mammalian and plant cells, demonstrating higher methylation efficiency compared to human DNMT3

Methodology Applied
Scientific EffectMethylation: Chemical Bonding

Data Source

PatentUS12428639B2Plant DNA methyltransferases and uses thereof
Publication Date: 2025.09.30 RAMOT AT TEL AVIV UNIVERSITY LTD
  • US12428639B2 patent drawing
  • US12428639B2 patent drawing
  • US12428639B2 patent drawing

AI summary

An isolated polynucleotide encoding a fusion protein which comprises a DNA targeting moiety linked to a catalytic domain of a plant DNA methyltransferase 3 (DNMT3) protein is disclosed. Uses thereof are also disclosed.